All News

Retinal cells may have potential to protect themselves from diabetic retinopathy

According to researchers, cells within retinal blood vessels are endowed with a previously unappreciated ability to acquire resistance against the damaging effects of hyperglycemia in patients with diabetes mellitus.

SparingVision’s lead asset SPVN06 clears IND application in US for treatment of retinitis pigmentosa

SPVN06 is a breakthrough gene therapy approach aimed at stopping or slowing disease progression in patients affected by IRDs and dry age-related macular degeneration (AMD), regardless of their genetic background.

Poll: Do you believe biosimilars have the same efficacy as branded medications?

Weigh in on this month's survey question. The poll will be open until December 16, 2022.

Patricia Piers, PhD, discusses a career of innovation in ophthalmology, looks to future

December 02, 2022

In a two-decade career as a researcher at Johnson & Johnson Surgical Vision, Piers has been a part of teams at the forefront of a number of innovations in IOLs. She discusses her career and the outlook for research and development in ophthalmology.